799 related articles for article (PubMed ID: 16982943)
1. Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study.
Modesti PA; Vanni S; Morabito M; Modesti A; Marchetta M; Gamberi T; Sofi F; Savia G; Mancia G; Gensini GF; Parati G
Circulation; 2006 Sep; 114(13):1410-6. PubMed ID: 16982943
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 and the pulmonary vascular response to altitude: a new therapeutic target?
Rubin LJ
Circulation; 2006 Sep; 114(13):1350-1. PubMed ID: 17000920
[No Abstract] [Full Text] [Related]
3. Endothelin receptors blockade blunts hypoxia-induced increase in PAP in humans.
Pham I; Wuerzner G; Richalet JP; Peyrard S; Azizi M
Eur J Clin Invest; 2010 Mar; 40(3):195-202. PubMed ID: 20415698
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary artery pressure limits exercise capacity at high altitude.
Naeije R; Huez S; Lamotte M; Retailleau K; Neupane S; Abramowicz D; Faoro V
Eur Respir J; 2010 Nov; 36(5):1049-55. PubMed ID: 20378601
[TBL] [Abstract][Full Text] [Related]
5. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
Holm P
Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
[TBL] [Abstract][Full Text] [Related]
6. Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials.
Smith TG; Talbot NP; Privat C; Rivera-Ch M; Nickol AH; Ratcliffe PJ; Dorrington KL; León-Velarde F; Robbins PA
JAMA; 2009 Oct; 302(13):1444-50. PubMed ID: 19809026
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic bosentan does not improve exercise capacity or lower pulmonary artery systolic pressure at high altitude.
Seheult RD; Ruh K; Foster GP; Anholm JD
Respir Physiol Neurobiol; 2009 Feb; 165(2-3):123-30. PubMed ID: 18977464
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone but not tadalafil improves exercise capacity in adults prone to high-altitude pulmonary edema.
Fischler M; Maggiorini M; Dorschner L; Debrunner J; Bernheim A; Kiencke S; Mairbäurl H; Bloch KE; Naeije R; Brunner-La Rocca HP
Am J Respir Crit Care Med; 2009 Aug; 180(4):346-52. PubMed ID: 19520908
[TBL] [Abstract][Full Text] [Related]
9. Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog.
Willette RN; Ohlstein EH; Mitchell MP; Sauermelch CF; Beck GR; Luttmann MA; Hay DW
J Pharmacol Exp Ther; 1997 Feb; 280(2):695-701. PubMed ID: 9023281
[TBL] [Abstract][Full Text] [Related]
10. Bosentan prevents hypoxia-reoxygenation-induced pulmonary hypertension and improves pulmonary function.
Pearl JM; Wellmann SA; McNamara JL; Lombardi JP; Wagner CJ; Raake JL; Nelson DP
Ann Thorac Surg; 1999 Nov; 68(5):1714-21; discussion 1721-2. PubMed ID: 10585047
[TBL] [Abstract][Full Text] [Related]
11. [Pathophysiology, prevention and therapy of altitude pulmonary edema].
Oelz O; Maggiorini M; Ritter M; Noti C; Waber U; Vock P; Bärtsch P
Schweiz Med Wochenschr; 1992 Aug; 122(31-32):1151-8. PubMed ID: 1496342
[TBL] [Abstract][Full Text] [Related]
12. The combination of theophylline and endothelin receptor antagonism improves exercise performance of rats under simulated high altitude.
Radiloff DR; Zhao Y; Boico A; Wu C; Shan S; Palmer G; Hamilton K; Irwin D; Hanna G; Piantadosi CA; Schroeder T
J Appl Physiol (1985); 2012 Oct; 113(8):1243-52. PubMed ID: 22898548
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil citrate for the prevention of high altitude hypoxic pulmonary hypertension: double blind, randomized, placebo-controlled trial.
Bates MG; Thompson AA; Baillie JK; Sutherland AI; Irving JB; Hirani N; Webb DJ
High Alt Med Biol; 2011; 12(3):207-14. PubMed ID: 21962063
[TBL] [Abstract][Full Text] [Related]
14. The endothelin antagonist bosentan: hemodynamic effects during normoxia and hypoxic pulmonary hypertension in pigs.
Holm P; Liska J; Clozel M; Franco-Cereceda A
J Thorac Cardiovasc Surg; 1996 Oct; 112(4):890-7. PubMed ID: 8873714
[TBL] [Abstract][Full Text] [Related]
15. The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness.
Penaloza D; Arias-Stella J
Circulation; 2007 Mar; 115(9):1132-46. PubMed ID: 17339571
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 in pulmonary hypertension associated with high-altitude exposure.
Goerre S; Wenk M; Bärtsch P; Lüscher TF; Niroomand F; Hohenhaus E; Oelz O; Reinhart WH
Circulation; 1995 Jan; 91(2):359-64. PubMed ID: 7805238
[TBL] [Abstract][Full Text] [Related]
17. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
Berger MM; Sareban M; Schiefer LM; Swenson KE; Treff F; Schäfer L; Schmidt P; Schimke MM; Paar M; Niebauer J; Cogo A; Kriemler S; Schwery S; Pickerodt PA; Mayer B; Bärtsch P; Swenson ER
J Appl Physiol (1985); 2022 Jun; 132(6):1361-1369. PubMed ID: 35511718
[TBL] [Abstract][Full Text] [Related]
18. [Who gets altitude sickness?].
Bärtsch P
Schweiz Med Wochenschr; 1992 Feb; 122(9):307-14. PubMed ID: 1546281
[TBL] [Abstract][Full Text] [Related]
19. Remote ischemic preconditioning does not prevent acute mountain sickness after rapid ascent to 3,450 m.
Berger MM; Macholz F; Lehmann L; Dankl D; Hochreiter M; Bacher B; Bärtsch P; Mairbäurl H
J Appl Physiol (1985); 2017 Nov; 123(5):1228-1234. PubMed ID: 28798201
[TBL] [Abstract][Full Text] [Related]
20. Prevention of high-altitude pulmonary edema by nifedipine.
Bärtsch P; Maggiorini M; Ritter M; Noti C; Vock P; Oelz O
N Engl J Med; 1991 Oct; 325(18):1284-9. PubMed ID: 1922223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
